Incidence of Early Pregnancy Loss in Patients With Unexplained Infertility

Unexplained fertility could be partly caused by a higher incidence of early pregnancy loss in this group. 65 women with unexplained infertility and 65 healthy controls will collect daily urine samples form the luteal phase. hCG and creatinine levels are measured in order to detect pregnancies and early pregnancy loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Abortion, Spontaneous Female Urogenital Diseases and Pregnancy Complications Genital Diseases Pregnancy Complications Urogenital Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

UMCUtrecht

Utrecht, 3508 GA, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Unexplained infertility

Exclusion criteria

IVF treatment

Treatment and study plan

Primary outcomes

incidence of early pregnancy loss

Time frame: 3 mentrual cycles

Secondary outcomes

incidence of pregnancies

Time frame: 3 menstual cycles

Sponsors and collaborators

Lead sponsor

UMC Utrecht

Other

Registry information

Official study title

Incidence of Early Pregnancy Loss in Patients With Unexplained Infertility Measured by hCG Rise in Urine

Acronym: UNEXPLAINED

Important dates

Study start: 2006
Primary completion: 2009
Study completion: 2009
First posted: Nov 18, 2009
Registry last updated: Nov 18, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed